Sheba’s doctors evaluate each patient to determine who is a suitable candidate for CAR T-cell therapy. Potential patients need to have undergone at least two leukemia treatments in the past. Currently, we provide this innovative treatment for the following diseases:

Following CAR T-cell therapy, the immune system needs to recover. In general, the full recovery period takes approximately 2-3 months, during which patients will be monitored closely for side effects and response to treatment. Most patients experience fatigue and a reduced appetite during this period, and driving and other potentially dangerous activities are not recommended.

CAR T-cell therapy is a highly personalized, cutting-edge treatment available at only a limited number of cancer centers worldwide, and Sheba Medical Center in Israel is one of those select centers. As the most advanced hospital in Israel and the most comprehensive medical facility in the region, Sheba is in the unique position of harboring […]